Muhsin Elçi
Research Subjects
Muhsin Elçi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alper Aytekin
Department of General Surgery, School of Medicine, Gaziantep University, Gaziantep 27310, Turkey
1 shared publication - Berat Ebik
Department of Gastroenterology, Diyarbakır Gazi Yasargil Education and Research Hospital, University of Health Sciences, Diyarbakır 21070, Turkey
1 shared publication - Göktürk Maralcan
SANKO ÜNİVERSİTESİ
1 shared publication - Mehmet Ali Melik
Department of General Surgery SANKO University Hospital Gaziantep Türkiye
1 shared publication - Nurullah Aksoy
Gaziantep Universitesi
1 shared publication
Latest Publications
- 19 May 2026
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 9 (3) , 664-670
Defensive medicine behaviors among general surgeons in Southeastern Anatolia: sociodemographic and professional associations
Aims: To evaluate defensive medical behaviors among general surgeons in Southeastern Anatolia and to examine their associations with selected sociodemographic and professional characteristics. Cross-sectional analytical study.Methods: General surgeons working in Southeastern Anatolia in 2025 were invited via Turkish Medical Association channels and hospital WhatsApp groups; the survey link was sent individually and completed online with one reminder. Of 138 invited surgeons, 64 completed the survey (46.4%), with no incomplete responses. Data were collected using a 38-item survey instrument (30 Likert-type items on defensive medicine attitudes and practices 8 demographic/professional questions) refined through structured expert review and pilot-tested before field implementation from three cities. Negatively worded items were reverse-scored, a composite mean score (1-5) was calculated, and internal consistency was assessed using Cronbach’s alpha. Group comparisons were performed using appropriate parametric or non-parametric tests.Results: A total of 64 surgeons participated (46.4%). The mean composite defensive behavior score was 3.42±0.59 (range 1.61-4.32) the instrument showed excellent internal consistency (Cronbach’s α=0.912). Higher scores were observed higher among married versus unmarried surgeons (3.55±0.54 vs 3.18±0.68; p=0.039), surgeons with versus without children (3.50±0.57 vs 3.29±0.45; p=0.047), and those working outside versus in their hometown (3.53±0.46 vs 3.28±0.72; p=0.027). No significant differences were found according to years in practice, annual surgical volume, malpractice lawsuit history, or workplace type.Conclusion: Defensive medical behavior was common in this sample and was associated with selected personal and contextual characteristics. These findings should be interpreted cautiously in view of the cross-sectional design and small subgroup sizes, and they warrant confirmation in larger multicenter studies.
- 19 May 2026
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 9 (3) , 664-670
Defensive medicine behaviors among general surgeons in Southeastern Anatolia: sociodemographic and professional associations
Aims: To evaluate defensive medical behaviors among general surgeons in Southeastern Anatolia and to examine their associations with selected sociodemographic and professional characteristics. Cross-sectional analytical study.Methods: General surgeons working in Southeastern Anatolia in 2025 were invited via Turkish Medical Association channels and hospital WhatsApp groups; the survey link was sent individually and completed online with one reminder. Of 138 invited surgeons, 64 completed the survey (46.4%), with no incomplete responses. Data were collected using a 38-item survey instrument (30 Likert-type items on defensive medicine attitudes and practices 8 demographic/professional questions) refined through structured expert review and pilot-tested before field implementation from three cities. Negatively worded items were reverse-scored, a composite mean score (1-5) was calculated, and internal consistency was assessed using Cronbach’s alpha. Group comparisons were performed using appropriate parametric or non-parametric tests.Results: A total of 64 surgeons participated (46.4%). The mean composite defensive behavior score was 3.42±0.59 (range 1.61-4.32) the instrument showed excellent internal consistency (Cronbach’s α=0.912). Higher scores were observed higher among married versus unmarried surgeons (3.55±0.54 vs 3.18±0.68; p=0.039), surgeons with versus without children (3.50±0.57 vs 3.29±0.45; p=0.047), and those working outside versus in their hometown (3.53±0.46 vs 3.28±0.72; p=0.027). No significant differences were found according to years in practice, annual surgical volume, malpractice lawsuit history, or workplace type.Conclusion: Defensive medical behavior was common in this sample and was associated with selected personal and contextual characteristics. These findings should be interpreted cautiously in view of the cross-sectional design and small subgroup sizes, and they warrant confirmation in larger multicenter studies.
- 17 February 2026
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 52
The Role of Intragastric Balloon Application in Non-Surgical Management of Obesity: Efficacy, Tolerance, and Complications
This study aimed to evaluate the weight-loss efficacy, tolerability, and safety of intragastric balloon (IGB) therapy as a minimally invasive alternative for patients who do not undergo bariatric surgery. Between June 2022 and October 2024, liquid-filled IGBs were endoscopically placed in 56 patients (aged 18–65 years, BMI > 27 kg/m²) who had failed to lose weight through lifestyle modifications. Following the exclusion of cases involving intolerance and one patient who required early removal due to pregnancy, data from 51 patients (51% female; mean age 29.4 years; mean baseline BMI 34.8 kg/m²) were retrospectively analyzed at the 6-month follow-up. Results demonstrated significant weight loss, with mean weight decreasing from 103.4 kg to 89.3 kg (−14.1 kg), representing a 13.7% Total Body Weight Loss (TBWL) and 57.5% Excess Weight Loss (EWL). Optimal results were observed in the BMI 30–35 kg/m² subgroup (TBWL 17.4%, EWL 68.9%; p<0.05). While advancing age showed a statistically significant positive correlation with weight loss, this relationship was modest in clinical strength. The treatment was well-tolerated, with only a 7.2% intolerance rate and no major complications. In conclusion, IGB therapy is a safe and effective short-term intervention, providing optimal results in patients with a BMI of 30–35 kg/m² and showing a modest positive correlation with advancing age.
- 17 February 2026
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 52
The Role of Intragastric Balloon Application in Non-Surgical Management of Obesity: Efficacy, Tolerance, and Complications
This study aimed to evaluate the weight-loss efficacy, tolerability, and safety of intragastric balloon (IGB) therapy as a minimally invasive alternative for patients who do not undergo bariatric surgery. Between June 2022 and October 2024, liquid-filled IGBs were endoscopically placed in 56 patients (aged 18–65 years, BMI > 27 kg/m²) who had failed to lose weight through lifestyle modifications. Following the exclusion of cases involving intolerance and one patient who required early removal due to pregnancy, data from 51 patients (51% female; mean age 29.4 years; mean baseline BMI 34.8 kg/m²) were retrospectively analyzed at the 6-month follow-up. Results demonstrated significant weight loss, with mean weight decreasing from 103.4 kg to 89.3 kg (−14.1 kg), representing a 13.7% Total Body Weight Loss (TBWL) and 57.5% Excess Weight Loss (EWL). Optimal results were observed in the BMI 30–35 kg/m² subgroup (TBWL 17.4%, EWL 68.9%; p<0.05). While advancing age showed a statistically significant positive correlation with weight loss, this relationship was modest in clinical strength. The treatment was well-tolerated, with only a 7.2% intolerance rate and no major complications. In conclusion, IGB therapy is a safe and effective short-term intervention, providing optimal results in patients with a BMI of 30–35 kg/m² and showing a modest positive correlation with advancing age.
- Open Access
- 1 January 2025
- Published by Acibadem Universitesi Saglik Bilimleri Dergisi in Acibadem Universitesi Saglik Bilimleri Dergisi
- Vol. 16 (Erken Çevr)
Evaluation of SIRT1-Regulating miRNAs in Breast Cancer: miR-9, miR-34a, and miR-132 Expression Analysis
Objectives: Breast cancer is one of the most common malignancy for women and one of the most common causes of cancer related deaths for women. Genetic factors and family history play major roles in its etiology. For a possible genetic treatment genetic pathway should be illuminated. Materials and methods: Three miRNAs known to be involved in the regulation of SIRT1 were selected for review in this study. These were miRNA-34a, miRNA-9 and miRNA-132 miRNAs. The miRNeasy Mini Kit was used to isolate total RNA from both cancer tissues and normal breast tissues in patients with breast cancer who underwent mastectomy for treatment. Expression levels of miRNAs were measured and normalized with U6 gene. Results: After measurment of expression levels, normalizing with U6 gene and statistical analysis, we found that there was no statistically significant difference between breast cancer tissues and normal breast tissues. Conclusion: Limited number of studies reported that the levels of all three micro RNAs were found to be lower in breast cancer tissues than in normal breast tissue. In this study, no statistically significant difference was found between normal breast tissue and breast cancer tissues in terms of levels of these micro RNAs for all three micro RNAs. The existence of conflicting and incomplete information about the SIRT1 enzyme did not surprise us with a result that is not compatible with the literature. Further studies are needed to clearly elucidate the mechanisms of SIRT1 and its regulating micro-RNAs. In the studies to be done, the determination of the microRNA levels simultaneously with SIRT1’s own expression levels can be enlightening on this issue.
- 1 January 2025
- Published by Acibadem Universitesi Saglik Bilimleri Dergisi in Acibadem Universitesi Saglik Bilimleri Dergisi
- Vol. 16 (Erken Çevr)
Open AccessEvaluation of SIRT1-Regulating miRNAs in Breast Cancer: miR-9, miR-34a, and miR-132 Expression Analysis
Objectives: Breast cancer is one of the most common malignancy for women and one of the most common causes of cancer related deaths for women. Genetic factors and family history play major roles in its etiology. For a possible genetic treatment genetic pathway should be illuminated. Materials and methods: Three miRNAs known to be involved in the regulation of SIRT1 were selected for review in this study. These were miRNA-34a, miRNA-9 and miRNA-132 miRNAs. The miRNeasy Mini Kit was used to isolate total RNA from both cancer tissues and normal breast tissues in patients with breast cancer who underwent mastectomy for treatment. Expression levels of miRNAs were measured and normalized with U6 gene. Results: After measurment of expression levels, normalizing with U6 gene and statistical analysis, we found that there was no statistically significant difference between breast cancer tissues and normal breast tissues. Conclusion: Limited number of studies reported that the levels of all three micro RNAs were found to be lower in breast cancer tissues than in normal breast tissue. In this study, no statistically significant difference was found between normal breast tissue and breast cancer tissues in terms of levels of these micro RNAs for all three micro RNAs. The existence of conflicting and incomplete information about the SIRT1 enzyme did not surprise us with a result that is not compatible with the literature. Further studies are needed to clearly elucidate the mechanisms of SIRT1 and its regulating micro-RNAs. In the studies to be done, the determination of the microRNA levels simultaneously with SIRT1’s own expression levels can be enlightening on this issue.